ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adkins, R. B.
Right arrow Articles by Hainsworth, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adkins, R. B., Jr
Right arrow Articles by Hainsworth, J. D.

The Annals of Thoracic Surgery, Vol 38, 648-659, Copyright © 1984 by The Society of Thoracic Surgeons


ARTICLES

Primary malignant mediastinal tumors

RB Adkins Jr, MD Maples and JD Hainsworth

Thirty-eight patients with primary malignant mediastinal tumors of all cell types are the basis for this review. Eleven of these patients had germ cell tumors. Five germ cell tumors were seminomas, two were malignant teratomas, and two were endodermal sinus tumors. Mean survival for all patients with germ cell tumors was 3.3 years. Eight children had surgical excision of mediastinal neuroblastomas, and all but 1 are alive for a mean survival of 6.7 years. Seven patients had lymphoproliferative disorders; 6 of these patients had nodular sclerosing Hodgkin's disease, and 1 had lymphoblastic (thymic) lymphoma. Mean survival was 5.1 years. There were five carcinomas of various cell types and one angiopericytoma. None of the patients with these lesions survived more than 2 years. Four patients had thymoma with an average survival of 3.7 years. Two patients had carcinoid tumors of thymic origin; neither survived more than 1 year. In 1972, we reported 5-year disease-free survival of 26% in a series of patients with primary mediastinal tumors. Our experience since 1970 shows current survival of 47.3% and 5-year disease-free survival of 34.2%. We use combined methods of therapy, including aggressive surgical resection, combination chemotherapy, and often mediastinal irradiation for most types of mediastinal tumors. Primary mediastinal malignancies should be treated aggressively using a multidisciplinary approach, since many of these tumors are curable.


This article has been cited by other articles:


Home page
Asian Cardiovasc. Thorac. Ann.Home page
C. P Shrivastava, S. Devgarha, and V. Ahlawat
Mediastinal Tumors: a Clinicopathological Analysis
Asian Cardiovasc Thorac Ann, April 1, 2006; 14(2): 102 - 104.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. E. Reed
General thoracic surgery and the Southern Thoracic Surgical Association: the second 25 years
Ann. Thorac. Surg., November 1, 2003; 76(90050): S14 - 16.
[Full Text] [PDF]


Home page
The OncologistHome page
R. Temes, N. Allen, T. Chavez, R. Crowell, C. Key, and J. Wernly
Primary Mediastinal Malignancies in Children: Report of 22 Patients and Comparison to 197 Adults
Oncologist, June 1, 2000; 5(3): 179 - 184.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
E. A. Bacha, A. R. Chapelier, P. Macchiarini, E. Fadel, and P. G. Dartevelle
Surgery for invasive primary mediastinal tumors
Ann. Thorac. Surg., July 1, 1998; 66(1): 234 - 239.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1984 by The Society of Thoracic Surgeons.